Hidekiyo Yamaki

Concurrent chemoradiotherapy with cisplatin and docetaxel for head and neck squamous cell carcinoma

M. Takahara, K. Kishibe, Michihisa Kono, 2021, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

Antitumor Peptide-Based Vaccine in the Limelight

Michihisa Kono, T. Kumai, H. Komatsuda, 2022, Vaccines.

IL-2 complex recovers steroid-induced inhibition in immunochemotherapy for head and neck cancer

M. Takahara, K. Kishibe, Michihisa Kono, 2022, Translational oncology.

Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapy

M. Takahara, K. Kishibe, Michihisa Kono, 2023, Cancer Immunology, Immunotherapy.

Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma

M. Takahara, K. Kishibe, Michihisa Kono, 2022, Oncoimmunology.

Interruption of MDM2 signaling augments MDM2-targeted T cell-based antitumor immunotherapy through antigen-presenting machinery

M. Takahara, K. Kishibe, E. Celis, 2021, Cancer Immunology, Immunotherapy.

Central-part laryngectomy after laryngotracheal separation to manage pharyngocutaneous fistula: A case report and retrospective analysis of 12 cases.

M. Takahara, Michihisa Kono, T. Kumai, 2022, Auris, nasus, larynx.

Effects of early nutritional intervention by a nutritional support team for patients with head and neck cancer undergoing chemoradiotherapy or radiotherapy

M. Takahara, Michihisa Kono, T. Kumai, 2020, Head & neck.

Mitogen‐activated protein kinase inhibition augments the T cell response against HOXB7‐expressing tumor through human leukocyte antigen upregulation

M. Takahara, Michihisa Kono, T. Kumai, 2022, Cancer Science.

The efficacy of PD‐1 inhibitors in patients with salivary gland carcinoma: A retrospective observational study

T. Kumai, T. Wada, Y. Harabuchi, 2022, Laryngoscope investigative otolaryngology.

Brachyury-targeted immunotherapy combined with gemcitabine against head and neck cancer

M. Takahara, K. Kishibe, Michihisa Kono, 2023, Cancer Immunology, Immunotherapy.

Mitogen‐activated protein kinase inhibition augments the T cell response against HOXB7‐expressing tumor through human leukocyte antigen upregulation

M. Takahara, Michihisa Kono, T. Kumai, 2022, Cancer Science.

Hypoxia-Targeted Immunotherapy with PD-1 Blockade in Head and Neck Cancer

K. Kishibe, T. Kumai, T. Nagato, 2024, Cancers.

Immunotherapy targeting tumor‐associated antigen in a mouse model of head and neck cancer

K. Kishibe, Michihisa Kono, T. Kumai, 2024, Head & neck.